Research Capital analyst Andre Greg McLeish reiterated a “Buy” rating and $3.50 price target on Cannara Biotech (Cannara Stock Quote, Chart, News, Analysts, Financials TSXV:LOVE) in a Feb. 4 special update, following the company’s recently completed strategic financing and progress toward a TSX uplisting. Cannara is a Canadian licensed producer of premium cannabis headquartered in […]
Roth Capital Markets analyst Bill Kirk reiterated a “Neutral” rating on Aurora Cannabis (Aurora Cannabis Stock Quote, Chart, News, Analysts, Financials TSX:ACB) and lowered his 12-month price target to C$5.00 from C$6.00 following what he described as a solid third-quarter beat that was quickly overshadowed by cautious implied fourth-quarter guidance. In a Feb. 5 sales […]
Share
Tweet
Share
